Because CT targets c-Myc and FAK in ovarian cancer cells, we hypothesized that this drug might induce apoptosis by functioning like a c-Myc inhibitor (Sheikh-Zeineddini et al., 2020). This evidence concerns the gene PTK2 and ovarian carcinoma.